Upifitamab (Anti-SLC34A2)

Ask supplier a question | View on supplier's website

Upifitamab (Anti-SLC34A2) is a humanized monoclonal antibody targeting NaPi2b. Upifitamab can be used to synthesize an ADC compound, Upifitamab rilsodotin, used in ovarian cancer research, particularly in platinum-resistant recurrent ovarian cancer. MW : 145.5 KD.

Supplier	Selleck Chemicals
Product #	A2351
Sku #	A2351-1mg*25
Pricing	1mg*25, $4170.00

Feedback